ERA, Congress

61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

ERA Congress United Kingdom United States of America France Germany Spain Sweden

View original content:https://www.prnewswire.co.uk/news-releases/61st-era-congress-semaglutide-significantly-reduces-risk-of-major-kidney-disease-events-cardiovascular-outcomes-and-mortality-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-groundbreaking-study-reveals-302152722.html

en | boerse | 67983465 |